Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$35.55 - $43.57 $539,009 - $660,608
-15,162 Reduced 47.37%
16,846 $731,000
Q3 2023

Nov 08, 2023

BUY
$39.13 - $47.24 $905,272 - $1.09 Million
23,135 Added 260.73%
32,008 $1.3 Million
Q2 2023

Aug 11, 2023

BUY
$43.93 - $46.76 $82,280 - $87,581
1,873 Added 26.76%
8,873 $399,000
Q1 2023

May 11, 2023

BUY
$45.29 - $50.76 $37,273 - $41,775
823 Added 13.32%
7,000 $321,000
Q4 2022

Feb 14, 2023

SELL
$41.91 - $50.48 $793,104 - $955,283
-18,924 Reduced 75.39%
6,177 $308,000
Q3 2022

Nov 14, 2022

BUY
$40.9 - $50.42 $763,725 - $941,492
18,673 Added 290.49%
25,101 $1.04 Million
Q2 2022

Aug 09, 2022

BUY
$42.98 - $49.77 $276,275 - $319,921
6,428 New
6,428 $303,000
Q1 2022

May 09, 2022

SELL
$42.23 - $54.3 $306,167 - $393,675
-7,250 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$50.62 - $56.47 $293,596 - $327,526
-5,800 Reduced 44.44%
7,250 $403,000
Q3 2021

Nov 10, 2021

BUY
$46.55 - $56.83 $607,477 - $741,631
13,050 New
13,050 $674,000
Q1 2021

May 14, 2021

SELL
$46.25 - $56.02 $254,375 - $308,110
-5,500 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$46.09 - $54.74 $64,526 - $76,636
1,400 Added 34.15%
5,500 $291,000
Q3 2020

Oct 15, 2020

BUY
$42.51 - $52.42 $174,291 - $214,922
4,100 New
4,100 $214,000
Q3 2019

Oct 16, 2019

SELL
$32.73 - $40.81 $165,024 - $205,764
-5,042 Closed
0 $0
Q2 2019

Jul 10, 2019

SELL
$35.73 - $41.39 $21,259 - $24,627
-595 Reduced 10.56%
5,042 $204,000
Q1 2019

May 10, 2019

BUY
$33.78 - $40.68 $190,417 - $229,313
5,637 New
5,637 $229,000
Q4 2017

Feb 14, 2018

SELL
$30.68 - $35.37 $551,933 - $636,306
-17,990 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$31.02 - $32.94 $558,049 - $592,590
17,990
17,990 $567,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.92B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.